4//SEC Filing
Celator Pharmaceuticals Inc 4
Accession 0001144204-15-034060
CIK 0001327467operating
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:01 PM ET
Size
8.2 KB
Accession
0001144204-15-034060
Insider Transaction Report
Form 4
Mayer Lawrence David
President and Head of Research
Transactions
- Exercise/Conversion
Common Stock
2015-05-14$2.25/sh+55,000$123,750→ 71,594 total - Exercise/Conversion
Stock Option, Right to Buy
2015-05-14−55,000→ 7,829 totalExercise: $2.25Exp: 2015-05-24→ Common Stock (55,000 underlying)
Holdings
- 3,631(indirect: By Trust)
Common Stock
- 7,468(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The option was fully exercisable. Options to purchase 7,829 shares expired on 5/24/15.
Documents
Issuer
Celator Pharmaceuticals Inc
CIK 0001327467
Entity typeoperating
Related Parties
1- filerCIK 0001327467
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 4:01 PM ET
- Size
- 8.2 KB